Home

Ajanta Pharma Ltd Quarterly Result

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

Net Profit - Last Quarter

₹ 216.48 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Ajanta Pharma Ltd for the Sep '24 is ₹ 1206 crore as compare to the Jun '24 revenue of ₹ 1171 crore. This represent the growth of 2.964852%.
  • The ebitda of Ajanta Pharma Ltd for the Sep '24 is ₹ 330.65 crore as compare to the Jun '24 ebitda of ₹ 356.82 crore. This represent the decline of -7.334234%.
  • The net profit of Ajanta Pharma Ltd for the Sep '24 is ₹ 216.48 crore as compare to the Jun '24 net profit of ₹ 245.77 crore. This represent the decline of -11.91765%.

Results Analysis

Market Price of Ajanta Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Ajanta Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20252879.5
14 Jan 20252814.85
13 Jan 20252783.75
10 Jan 20252835.65
09 Jan 20252934.75
08 Jan 20252971.45
07 Jan 20252997.4
06 Jan 20252948.8
03 Jan 20252871.3
02 Jan 20252973.05

Historical Revenue of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Ajanta Pharma Ltd

No data available

* All values are in crore

Ajanta Pharma Ltd News Hub

Ajanta Pharma fixes record date for interim dividend

Ajanta Pharma has fixed 06 November 2024 as record date for payment of interim dividend, if declared

Read more

23 Oct 2024

Ajanta Pharma Ltd eases for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2974.35, do

Read more

23 Oct 2024

Ajanta Pharma to hold board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 October 2024. Power

Read more

17 Oct 2024

Board of Ajanta Pharma recommends First Interim Dividend

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 28 October

Read more

28 Oct 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

May 2024

Transcript

Oct 2023

Transcript

July 2023

Transcript

May 2023

Transcript

Aug 2022

Transcript

FAQs for Quarterly Results of Ajanta Pharma Ltd

What key financial metrics are included in Ajanta Pharma Ltd's quarterly results?

Key financial metrics in Ajanta Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Ajanta Pharma Ltd announce its quarterly results?

Ajanta Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Ajanta Pharma Ltd's quarterly performance impact its stock price?

Ajanta Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Ajanta Pharma Ltd's quarterly results on dividends?

The impact of Ajanta Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Ajanta Pharma Ltd's quarterly results?

Yes, Ajanta Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions